Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines

T Capelôa, Z Benyahia, LX Zampieri… - Seminars in cell & …, 2020 - Elsevier
Abstract Anthracyclines Doxorubicin, Epirubicin, Daunorubicin and Idarubicin are used to
treat a variety of tumor types in the clinics, either alone or, most often, in combination …

[HTML][HTML] Histone deacetylases and histone deacetylase inhibitors in neuroblastoma

M Phimmachanh, JZR Han, YEI O'Donnell… - Frontiers in cell and …, 2020 - frontiersin.org
Histone deacetylases (HDACs) are enzymes that play a key role in regulating gene
expression by remodeling chromatin structure. An imbalance of histone acetylation caused …

Integrative analysis of gene expression and DNA methylation through one‐class logistic regression machine learning identifies stemness features in medulloblastoma

H Lian, YP Han, YC Zhang, Y Zhao, S Yan… - Molecular …, 2019 - Wiley Online Library
Most human cancers develop from stem and progenitor cell populations through the
sequential accumulation of various genetic and epigenetic alterations. Cancer stem cells …

[HTML][HTML] Cancer stem cells in neuroblastoma: expanding the therapeutic frontier

HF Bahmad, F Chamaa, S Assi… - Frontiers in molecular …, 2019 - frontiersin.org
Neuroblastoma (NB) is the most common extracranial solid tumor often diagnosed in
childhood. Despite intense efforts to develop a successful treatment, current available …

[HTML][HTML] The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro

O Piskareva, H Harvey, J Nolan, R Conlon, L Alcock… - Cancer letters, 2015 - Elsevier
Neuroblastoma is a challenging childhood malignancy, with a very high percentage of
patients relapsing following acquisition of drug resistance, thereby necessitating the …

[HTML][HTML] Acetylation and deacetylation in cancer stem-like cells

N Liu, S Li, N Wu, KS Cho - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cancer stem-like cell (CSC) model has been established to investigate the underlying
mechanisms of tumor initiation and progression. The imbalance between acetylation and …

Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?

SR Martins-Neves, AM Cleton-Jansen… - Pharmacological …, 2018 - Elsevier
The development of local recurrence and metastatic disease, most probably attributable to
the intrinsic or acquired resistance of tumor cells to standard therapy, still constitute the …

Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance

Z Payandeh, AP Tazehkand, G Barati, F Pouremamali… - Biochimie, 2020 - Elsevier
Cancer stem cells (CSCs) are rare sub-population in tumor mass with self-renewal and
differentiation abilities; CSCs are considered as the main cells which are responsible for …

[HTML][HTML] Roles of S100 family members in drug resistance in tumors: Status and prospects

X Hua, H Zhang, J Jia, S Chen, Y Sun, X Zhu - Biomedicine & …, 2020 - Elsevier
Chemotherapy and targeted therapy can significantly improve survival rates in cancer, but
multiple drug resistance (MDR) limits the efficacy of these approaches. Understanding the …

Drug repurposing towards targeting cancer stem cells in pediatric brain tumors

HF Bahmad, MK Elajami, T El Zarif… - Cancer and Metastasis …, 2020 - Springer
In the pediatric population, brain tumors represent the most commonly diagnosed solid
neoplasms and the leading cause of cancer-related deaths globally. They include low-grade …